NCT03022422View on ClinicalTrials.gov

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011

PHASE4CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Influenza
Interventions
BIOLOGICAL

TIV

Influenza Virus Vaccine Suspension for Intramuscular Injection

BIOLOGICAL

High-Dose TIV

High-Dose Influenza Virus Vaccine supplied in a prefilled, single-dose syringe for intramuscular injection

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Stanford University

OTHER

NCT03022422 - T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011 | Biotech Hunter | Biotech Hunter